Phase III, minimally invasive surgery plus rt-PA in the treatment of intracerebral haemorrhage trial (MISTIE III)

An international clinical trial to determine the effectiveness of minimally invasive surgery plus intravenous rtPA (or alteplase) in patients with moderate-severe intracerebral haemorrhage (ICH).